{
    "root": "2f8a6c7b-1e01-eaaa-e063-6294a90a988d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Quetiapine Fumarate",
    "value": "20250304",
    "ingredients": [
        {
            "name": "DIBASIC CALCIUM PHOSPHATE DIHYDRATE",
            "code": "O7TSZ97GEP"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "QUETIAPINE FUMARATE",
            "code": "2S3PL1B6UJ"
        }
    ],
    "indications": "quetiapine atypical antipsychotic indicated treatment : \u00b7 schizophrenia ( 1.1 ) \u00b7 bipolar disorder manic episodes ( 1.2 ) \u00b7 bipolar disorder , depressive episodes ( 1.2 )",
    "contraindications": "\u00b7 quetiapine tablets , usp taken without food ( 2.1 ) indication initial dose recommended dose maximum dose schizophrenia-adults ( 2.2 ) 25 mg twice daily 150 750 mg/day 750 mg/day schizophrenia-adolescents ( 13 17 years ) ( 2.2 ) 25 mg twice daily 400 800 mg/day 800 mg/day bipolar mania- adults monotherapy adjunct lithium divalproex ( 2.2 ) 50 mg twice daily 400 800 mg/day 800 mg/day bipolar mania- children adolescents ( 10 17 years ) , monotherapy ( 2.2 ) 25 mg twice daily 400 600 mg/day 600 mg/day bipolar depression-adults ( 2.2 ) 50 mg daily bedtime 300 mg/day 300 mg/day \u00b7 geriatric : consider lower starting dose ( 50 mg/day ) , slower titration careful monitoring initial dosing period elderly ( 2.3 , 8.5 ) \u00b7 hepatic impairment : lower starting dose ( 25 mg/day ) slower titration may needed ( 2.4 , 8.7 , 12.3 )",
    "warningsAndPrecautions": "quetiapine tablets , usp 300 mg white coloured , film coated , capsule shaped , biconvex tablets , debossed `` 259 `` one side plain side . ndc : 70518-2113-00 packaging : 30 1 blister pack store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "hypersensitivity quetiapine excipients quetiapine formulation . anaphylactic reported patients treated quetiapine .",
    "indications_original": "Quetiapine is an atypical antipsychotic indicated for the treatment of: \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Schizophrenia ( 1.1 ) \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bipolar I disorder manic episodes ( 1.2 ) \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bipolar disorder, depressive episodes ( 1.2 )",
    "contraindications_original": "\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Quetiapine tablets, USP can be taken with or without food ( 2.1 ) Indication Initial Dose Recommended Dose Maximum Dose Schizophrenia-Adults (2.2) 25 mg twice daily 150 to 750 mg/day 750 mg/day Schizophrenia-Adolescents (13 to 17 years) (2.2) 25 mg twice daily 400 to 800 mg/day 800 mg/day Bipolar Mania- Adults Monotherapy or as an adjunct to lithium or divalproex (2.2) 50 mg twice daily 400 to 800 mg/day 800 mg/day Bipolar Mania- Children and Adolescents (10 to 17 years), Monotherapy (2.2) 25 mg twice daily 400 to 600 mg/day 600 mg/day Bipolar Depression-Adults (2.2) 50 mg once daily at bedtime 300 mg/day 300 mg/day \u00b7 Geriatric Use: Consider a lower starting dose (50 mg/day), slower titration and careful monitoring during the initial dosing period in the elderly ( 2.3 , 8.5 ) \u00b7 Hepatic Impairment: Lower starting dose (25 mg/day) and slower titration may be needed ( 2.4 , 8.7 , 12.3 )",
    "warningsAndPrecautions_original": "Quetiapine tablets, USP 300 mg\n                  White coloured, film coated, capsule shaped, biconvex tablets, debossed with \"259\" on one side and plain on other side.\n                  \n                  NDC: 70518-2113-00\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to\u00a077\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [see USP Controlled Room Temperature].\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Hypersensitivity to quetiapine or to any excipients in the quetiapine formulation. Anaphylactic reactions have been reported in patients treated with quetiapine."
}